We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

I asked ChatGPT for the best FTSE 100 shares to consider for 2026, and it said…

Whatever an individual investor’s favourite strategy, I reckon there’s something for everyone among the shares in the FTSE 100.

| More on:

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

ChatGPT’s found me some popular FTSE 100 shares to mull going into the New Year. But I think some would put me on the road to nowhere. So I’ve had to use my human brain to barrow down my search criteria and pick candidates in three different categories.

Looking for relatively safe blue-chips, pharmaceutical giant AstraZeneca (LSE: AZN) is one I’ll definitely look at. AstraZeneca has a forward price-to-earnings (P/E) ratio of 27, with the share price having soared 90% in the past five years. With a forecast dividend yield of just 1.7%, it might not look great value, but as defensive stocks go, it has to be a consideration.

XXX

With the latest update in November, CEO Pascal Soriot spoke of “an unprecedented 16 positive Phase III trials this year, with four since our previous results including high-impact readouts for baxdrostat in hypertension and Enhertu and Datroway in breast cancer.

He also pointed to expansion in the US, with construction of the company’s new $4.5bn manufacturing facility in Virginia already commenced. These highlight the key strengths for me. AstraZeneca’s share valuation might be the biggest danger, especially if investors move away from safety in 2026. But its very strong pipeline and global market reach lead me to rate it a definite long-term consideration.

FTSE 100 growth

The FTSE 100 isn’t really home to many growth candidates, but Rio Tinto (LSE: RIO) enjoyed a bit of cyclical growth in the latter half of 2025. And with the share price up only 7% in five years, I see a good chance of more to come.

Global demand for metals has been strong. I can see solid demand for quite some time yet, especially if China gets back into top gear. Even with a slight slowdown predicted, GDP growth for the country is expected to come in between 4% and 5% this year. Most Western economies can only dream of that.

My main concern is if precious metal fever subsides — which it surely must, right? Rio does produce some gold and silver, and it could take a hit. But it’s a major supplier of copper, aluminium and iron. And it also unearths lithium, selenium, molybdenum and many more in demand by various high-tech industries. Add in a 4.8% forecast dividend yield, and Rio Tinto has to be one to consider for 2026.

Show me the cash

For FTSE 100 income, I like the 4.7% dividend yield on the cards for Prudential (LSE: PRU). That’s higher than we were used to from the Pru of old. And it comes even after the share price has gained nearly 50% in five years. It is however, worth noting that the share price is only about where it was back in 2018.

Maybe today’s higher valuation could weigh against the stock in the future. This is a cyclical business, after all — and a P/E of 14 might be a bit toppy for the sector.

But I reckon Prudential’s key strength lies in its Asian prospects. At Q3 time, CEO Anil Wadhwani praised the “particular focus on ASEAN markets where we see an opportunity to build on the agency new business profit growth achieved in the markets of Greater China.”

So I’m considering the Pru for my 2026 Stocks and Shares ISA.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has recommended AstraZeneca Plc and Prudential Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

£503 buys 14 shares in this FTSE 250 stock that returned 23.9% annually for the last 15 years

This FTSE 250 stock has averaged a huge return for 15 years. At today's price, £503 buys 14 shares. But…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

£1,000 buys 25 shares in this FTSE 100 stock that’s returned 29.2% annually for the last 10 years

This FTSE 100 mining stock has returned close to 30% a year for a decade. At 3,995p, £1,000 buys 25…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Down 47%, is this growth stock finally worth buying in May?

With a £288m order book and a hidden pipeline of defence and nuclear contracts, is this growth stock now too…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

2 REITs yielding 7%+ to consider for passive income in 2026

A REIT backed by the NHS and another backed by Tesco and Sainsbury's with both yielding 7%+. Here's why I'm…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Just 97 shares of this UK dividend stock generate £238 in passive income

A 5.7% yield, £238 in passive income from just 97 shares, and one of the most divisive dividend stocks on…

Read more »

ISA coins
Investing Articles

£10,000 in an ISA generates a second income of…

The London Stock Exchange is home to some of the world's most generous dividends. But how big a second income…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Expert recommendations: 2 top income stocks yielding 7%+!

With yields of 7.2% and 7.8% respectively, these two income stocks are catching the eyes of institutional analysts. Should investors…

Read more »

Illustration of flames over a black background
Investing Articles

3 top income-focused stocks to buy in May 2026, according to experts

Looking for a stock to buy for income in May 2026? Experts have flagged these three UK dividend shares as…

Read more »